Cyclarity Therapeutics
Developer of compound-based drugs designed to treat the underlying causes of age-related diseases. The company's drugs offer simple and direct interventions targeting toxic forms of cholesterol, using...
Valuation
$34.3M
Market implied
Share Price
N/A
Total Raised
$24.2M
Last Round
N/A